Open Access
Review Article
September-October 2026, Vol. 02 (5), 45-59
International Journal of Pharmaceutical
Research and Medicinal Plants
(An International Peer Reviewed Journal)
Controlled Drug Delivery Systems: Mechanisms, Drug Selection, and
Formulation Approaches
Vivek Dinanath Parab
1
*
and Kashish Irfan Kazi
2
1
Lecturer-Department of Pharmacy, Vijayrao Naik College of Pharmacy, Shirval-416620
² Student- Shree Pushpasen Sawant College of D-Pharmacy Post Digas, Tal. Kudal, 416521
ARTICLE INFO:
ABSTRACT
Received:
30
th
Sept.
2026
;
Received
in
revised form: 03
rd
Oct. 2026
;
Accepted:
10
th
Oct.
2026
;
Available
online:
30
th
Oct. 2026.
Keywords:
Controlled drug delivery
systems, Sustained release, Diffusion-
controlled systems, Osmotic drug
delivery, Drug selection.
DOI:
https://doi.org/10.61280/6jj8a660
*Corresponding
Author:
Vivek
Dinanath Parab
Email:
vivek8523parab@gmail.com
Controlled
Drug
Delivery
Systems
(CDDS)
are
pharmaceutical
formulations designed to regulate the rate and duration of drug release
to maintain therapeutic drug concentrations over an extended period.
Compared
with
conventional
dosage
forms,
these
systems
aim
to
reduce fluctuations
in
drug concentration, decrease the frequency of
drug
administration,
and
improve
patient
compliance.
This
review
discusses the major principles and mechanisms involved in controlled
drug
delivery,
including
dissolution-controlled,
diffusion-controlled,
erosion-controlled,
ion-exchange-controlled,
and
osmotic
systems.
It
also
highlights
the
importance
of
selecting
suitable
drug
candidates
based
on
their
physicochemical,
biopharmaceutic,
pharmacokinetic,
and pharmacodynamic properties. Factors such as molecular weight,
aqueous
solubility,
partition
coefficient,
drug
stability,
absorption
characteristics, biological half-life, metabolism, therapeutic range, and
therapeutic
index
influence
the
suitability
of
a
drug
for
controlled
release.
Understanding
these
properties
is
essential
for
selecting
an
appropriate
drug
delivery
approach
and
designing
formulations
capable of providing predictable and sustained drug release. Overall,
controlled
drug
delivery
offers
an
important
approach
to
improving
dosage
convenience
and
maintaining
therapeutic
effectiveness,
although
its
success
depends
on
appropriate
drug
selection
and
formulation design.
1. INTRODUCTION
Drug delivery systems play an important role in the administration of therapeutic agents for the prevention
and treatment of various diseases. Among the different routes of drug administration, the oral route is widely
preferred because of its convenience, ease of administration, and patient acceptability. Conventional dosage
forms, particularly tablets and capsules, are extensively used for oral drug delivery. However, these dosage
forms have certain limitations associated with dosing frequency, fluctuations in plasma drug concentrations,
and
maintenance
of
therapeutic
activity
over
an
extended
period.
Following
the
administration
of
a
conventional dosage form, the drug is released and absorbed into the systemic circulation, resulting in an
increase in plasma drug concentration. As the drug undergoes distribution, metabolism, and elimination, its
Copyright:
©
Author
2026
by
the
Author.
International
Journal
of
Pharmaceutical
Research
and
Medicinal
Plants
Published
by
Informative Journals
(Jadoun Science Publishing Group India). This article is an open access article distributed under the terms and conditions
of the CC BY-NC-ND 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 45
concentration
gradually
decreases.
When
the
plasma
concentration
falls
below
the
minimum
effective
concentration, the desired therapeutic effect may no longer be maintained, necessitating the administration of
another
dose.
Conversely,
excessive
drug
concentrations
may
exceed
the
therapeutic
range
and
produce
undesirable effects or toxicity. Consequently, conventional dosage forms may produce fluctuations in plasma
drug concentrations, which can affect therapeutic efficacy and drug safety.[1]
Controlled
drug
delivery
systems
(CDDS):
have
been
developed
to
overcome
some
of
the
limitations
associated with conventional dosage forms by regulating the rate and duration of drug release. These systems
are
designed
to
deliver
a
drug
at
a
predetermined
rate
over
a
specified
period,
with
the
objective
of
maintaining
its
concentration
within
the
desired
therapeutic
range.
Depending
on
the
formulation
design,
controlled
drug
delivery
may
also
regulate
the
time
or
location
of
drug
release.
The
development
of
controlled
drug
delivery
systems
is
based
on
the
modification
of
drug-release
characteristics
through
appropriate
formulation
approaches.
The
release
of
a
drug
may
be
regulated
by
mechanisms
such
as
diffusion,
dissolution,
ion
exchange,
and
osmotic
pressure.
The
selection
of
a
suitable
delivery
system
depends on the physicochemical properties of the drug, its pharmacokinetic characteristics, the intended route
of administration, and the desired therapeutic response.
Controlled
drug
delivery
systems
offer
several
potential
advantages
over
conventional
dosage
forms,
including
reduced
dosing
frequency,
improved
patient
compliance,
reduced
fluctuations
in
plasma
drug
concentrations,
and
prolonged
therapeutic
activity.
However,
their
performance
depends
on
appropriate
formulation design, and limitations such as dose dumping, formulation complexity, manufacturing costs, and
difficulties in predicting in vivo drug-release behaviour must also be considered.
Therefore, understanding the fundamental principles of controlled drug delivery, the mechanisms governing
drug release, and the physicochemical and biological properties of drug candidates is essential for the rational
development of these formulations. These considerations provide the basis for selecting suitable drugs and
designing delivery systems capable of achieving the intended drug-release profile.[1-2]
Bioavailability Profile of Drug after Oral Administration;
After oral administration, the drug is absorbed
into
the
bloodstream,
causing
its
plasma
concentration
to
increase.
When
the
concentration
reaches
the
Minimum
Effective
Concentration
(MEC),
the
therapeutic
effect
begins.
The
concentration
rises
to
its
maximum
level
(Cmax)
at
a
particular
time
(tmax).
Subsequently,
metabolism
and
elimination
cause
the
concentration to decrease. The therapeutic effect continues as long as the concentration remains above the
MEC. The area under the curve (AUC) represents the extent of systemic drug exposure, while the Maximum
Safe Concentration (MSC) indicates the upper safe concentration limit shown in the figure.1
Figure 1.1:
Bioavailability profile of drug after oral administration. The curve plotted between plasma drug
concentration
vs.
time,
showing
all
the
pharmacokinetic
parameters,
where;
MEC-minimum
effective
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 47
concentration;
MSC-
maximum
safe
concentration;
AUC-
area
under
curve;
Cmax
maximum
drug
concentration and tmax maximum time.
Following the administration of conventional dosage forms, the plasma drug concentration increases during
absorption
and
decreases
during
elimination.
Repeated
administration
produces
fluctuations
in
drug
concentration, resulting in a peak-and-valley pattern. The drug concentration may fall below the minimum
effective concentration (MEC), reduce therapeutic effectiveness, or rise excessively, increasing the risk of
adverse
effects.
Therefore,
repeated
doses
are
required
to
maintain
the
drug
concentration
within
the
therapeutic range.[1-3]
Figure 1.2:
Fluctuation in Plasma Concentration of Drug Following Conventional Dosage Forms
Rationale
of
Controlled
Drug
Delivery
Systems
(CDDS):
The
primary
objective
of
controlled
drug
delivery is to modify the pharmacokinetic and pharmacodynamic properties of a drug. This can be achieved
by developing a novel drug delivery system or by modifying the drug’s molecular structure and physiological
parameters. A properly designed dosage form should maintain drug action over an extended period. The main
aim of controlled drug delivery is to ensure drug safety, improve therapeutic efficacy, and enhance patient
compliance
through
better
regulation
of
plasma
drug
concentrations
and
reduced
dosing
frequency.
In
conventional dosage forms, the dose and dosing interval are the main parameters that can be adjusted. Each
drug
has
a
specific
therapeutic
window.
When
the
plasma
drug
concentration
falls
below
the
minimum
effective concentration (MEC), the desired therapeutic effect
may not
be achieved. Conversely, when the
concentration
exceeds
the
maximum
safe
concentration
(MSC),
toxic
effects
may
occur.
The
therapeutic
index is expressed as the ratio of the median lethal dose (LD₅₀) to the median effective dose (ED₅₀).
-
1.
To provide location-specific action within the gastrointestinal tract (GIT):
To deliver the drug to
a particular site within the GIT where its action is required.
-
2.
To avoid undesirable local action within the GIT:
To prevent unwanted local effects of the drug
within the gastrointestinal tract.
-
3.
To
provide
a
programmed
delivery
pattern:
To
release
the
drug
according
to
a
predetermined
pattern.
-
4.
To increase the rate and extent of absorption and bioavailability:
To improve the rate and amount
of drug absorbed into the body.
-
5.
To extend the duration of drug action:
To prolong the therapeutic action of the drug over a longer
period.[4]
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 48
Figure 1.3:
No fluctuation in plasma concentration of drug following controlled release dosage form
General Advantages of Controlled Drug Delivery Systems (CDDS)
-
1.
Maintenance of drug concentration: Maintains drug concentration within the desired therapeutic range
for an extended period.
-
2.
Reduced dosing frequency: Reduces the frequency of drug administration, improving convenience for
patients.
-
3.
Improved patient compliance: Simplifies the dosing regimen and helps improve patient adherence to
treatment.
-
4.
Reduced overdosage
and underdosage: Helps prevent fluctuations in drug concentration associated
with conventional dosage forms.
-
5.
Reduced
adverse
effects:
Minimizes
local
and
systemic
side
effects
by
maintaining
drug
concentrations within the desired range.
-
6.
Improved
therapeutic
efficacy
and
safety:
Provides
better
control
of
plasma
drug
concentrations,
helping improve the effectiveness and tolerability of treatment.
-
7.
Reduced total drug consumption: May reduce the total amount of drug required to achieve the desired
therapeutic effect.
-
8.
Reduced drug accumulation: Helps minimize excessive drug accumulation in the body.
-
9.
Improved bioavailability: May improve the bioavailability of certain drugs.
-
10.
Prolonged duration of action: Extends the therapeutic action of the drug and may reduce the need for
frequent administration.[1,5]
Disadvantages of Controlled Drug Delivery Systems (CDDS)
-
1.
High cost: Controlled drug delivery systems are generally more expensive than conventional dosage
forms.
-
2.
Unpredictable performance: Their performance may be difficult to predict, and correlations between
in vitro and in vivo drug release may be poor.
-
3.
Risk of dose dumping: Failure of the drug-release system may result in the rapid release of a large
amount of drug, potentially causing toxic effects.
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 49
-
4.
Limited
dose
adjustment:
These
systems
offer
less
flexibility
for
adjusting
the
dose
once
administered.
-
5.
Increased
first-pass
clearance:
Some
drugs
may
undergo
increased
first-pass
clearance,
which
can
reduce their systemic availability.
-
6.
Poor
systemic
availability:
Certain
controlled-release
formulations
may
result
in
poor
systemic
availability of the drug.
-
7.
Limited release duration: For some oral controlled-release formulations, drug release may be limited
by the residence time of the dosage form in the stomach and gastrointestinal tract.
-
8.
Delayed
onset
of
action:
Controlled-release
formulations
may
take
longer
to
produce
the
desired
therapeutic effect than conventional dosage forms.
-
9.
Limited
drug
suitability:
Not
all
drugs
are
suitable
for
incorporation
into
controlled
drug
delivery
systems.[1,5]
Selection
of
Drug
Candidates
for
Controlled-Release
Dosage
Forms:
Not
all
drugs
are
suitable
for
formulation as controlled-release dosage forms. The selection of a suitable drug candidate depends on several
characteristics, including its elimination half-life, therapeutic index, absorption rate, absorption mechanism,
and first-pass effect.
-
1.
Very
short
elimination
half-life:
The
elimination
half-life
of
a
drug
is
an
important
consideration
when selecting candidates for controlled-release formulations. Drugs with a very short elimination
half-life require particular consideration because their duration in the body is limited.
-
2.
Very long elimination half-life: Drugs with a very long elimination half-life must also be evaluated
when
designing
controlled-release
dosage
forms,
as
their
elimination
characteristics
influence
the
suitability of prolonged drug delivery.
-
3.
Narrow
therapeutic
index:
The
therapeutic
index
is
an
important
parameter
in
drug
selection.
It
represents
the
relationship
between
a
drug's
toxic
and
effective
doses.
Drugs
with
a
narrow
therapeutic index require careful consideration because maintaining drug concentrations within the
appropriate therapeutic range is important.
-
4.
Rate of absorption: The rate at which a drug is absorbed influences the design of a controlled-release
formulation. Therefore, the absorption rate must be considered when selecting a drug candidate.
-
5.
Mechanism of absorption: The mechanism by which a drug crosses biological membranes is another
important consideration. Understanding the absorption mechanism helps determine the suitability of
the drug for controlled-release delivery.
-
6.
First-pass effect: The first-pass effect must be considered when selecting a drug for controlled-release
formulation
because
it
influences
the
amount
of
drug
that
reaches
the
systemic
circulation
after
administration.[7]
Approaches
to
the
Design
of
Controlled-Release
Formulations:
The
design
and
development
of
controlled-release
formulations
primarily
involve
two
approaches:
modification
of
the
drug
molecule
and
modification
of
the
dosage
form.
These
approaches
form
the
basis
for
developing
controlled-release
and
sustained-release dosage forms.
The chapter
further indicates that oral
controlled-release
formulations are
predominantly designed using physical mechanisms, whereas chemical degradation, enzymatic degradation,
and prodrug approaches are used less frequently. Depending on the release mechanism, controlled-release
formulations may be designed using a single mechanism or a combination
of mechanisms to
achieve the
desired drug-release characteristics.
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 50
The modified-release dosage form can be categorized into the following;
-
•
Delayed release
-
•
Extended-release
-
•
Sustained release
-
•
Controlled release
-
•
Timed release
-
•
Prolonged release
Broadly the modified release dosage form can be classified as below (Fig. 1.4),[4,8]
Figure 1.4:
Classification of Modified-Release Dosage Forms
Based on the mechanism of drug release and the carrier used, modified-release dosage forms can be
classified into the following six categories:
1. Diffusion-Sustained Systems
-
•
(a) Reservoir type
-
•
(b) Matrix type
2. Dissolution-Sustained Systems
-
•
(a) Reservoir type
-
•
(b) Matrix type
3. Ion-Exchange Methods
4. Methods Using Osmotic Pressure
5. pH-Independent Formulations
6. Altered-Density Formulations[9]
Dissolution-Controlled
Release:
Dissolution-controlled
release
systems
are
commonly
prepared
as
sustained-release oral formulations in which the dissolution of the drug determines the rate of release. When
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 51
a drug dissolves rapidly, it is combined with a carrier that dissolves slowly and formulated into a tablet to
maintain or control drug release.
When dissolution is controlled by the diffusion layer, the rate-limiting step is the movement of the drug from
the solid surface into the bulk solution through an unstirred liquid film. Under steady-state conditions, this
process can be expressed using the Noyes–Whitney equation.
Two approaches are used to prepare dissolution-controlled formulations:
-
1.
Dissolution-controlled encapsulated or coated systems.
-
2.
Dissolution-controlled matrix systems.
Dissolution-Controlled Encapsulation:
In this approach, individual drug particles or granules are coated
with a material that dissolves slowly. The coated particles are then directly compressed into tablets. Space
Tabs and Spansules are examples of this type of formulation.[9,10]
Dissolution-Controlled Matrix:
In this method, the drug is combined with a slowly dissolving carrier to
form
a
matrix,
which
is
subsequently
compressed
into
a
tablet.
Drug
bioavailability
is
regulated
by
the
penetration of the dissolution medium into the matrix. This penetration is influenced by the porosity of the
tablet matrix, the presence of hydrophilic materials, tablet wettability, and particle surface area.
Poorly water-
soluble drugs, classified as BCS Class II and IV, naturally tend to exhibit sustained release. For water-soluble
drugs, a water-insoluble carrier is incorporated into the formulation to decrease the dissolution rate of the
drug
particles.
These
particles
may
be
precoated
with
materials
such
as
polyethylene
glycol.
In
such
formulations, a disintegrating agent may not be included because it could interfere with the intended delayed-
release effect.[11]
Erosion-Controlled Systems:
Erosion-controlled drug delivery systems are also known as stimuli-induced
systems. Their release mechanism is activated by an external stimulus, such as pH, temperature, enzymes, or
osmotic pressure. The drug is released as the surface or bulk of the formulation undergoes erosion.
When the
surrounding
pH
is
unsuitable
for
drug
dissolution,
the
drug
may
remain
unreleased,
as
occurs
with
pH-
sensitive
dosage
forms.
Polymers
are
commonly
used
to
coat
these
formulations.
Acrylates,
including
methacrylic acid copolymers, and cellulose esters, such as cellulose acetate phthalate, are used for coating
pH-sensitive systems. These polymers may also be employed in the preparation of matrix systems.[12-13]
Hybrid Systems:
Hybrid systems combine the robust matrix structure of matrix systems with the constant-
release characteristics of reservoir systems. The drug is incorporated or entrapped within a release-controlling
matrix,
which
is
subsequently
coated
with
a
polymer.
High-molecular-weight
compounds
may
also
be
incorporated into these systems.
Advantages of hybrid systems:
Diffusion-Controlled Release
Diffusion-controlled systems can be divided into two types:
-
1.
Diffusion-controlled encapsulation.
-
2.
Systems in which osmotic pressure is the rate-limiting factor.
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 52
Diffusion-Controlled Encapsulation
In diffusion-controlled formulations, drug molecules pass through a polymer membrane or polymer matrix
and
are
released.
Depending
on
whether
the
polymer
forms
a
surrounding
membrane
or
is
distributed
throughout the formulation, these systems are classified into:
-
•
Reservoir systems.
-
•
Monolithic systems.
In
nonporous
reservoir
systems,
drug
molecules
move
through
the
polymer
membrane.
In
microporous
reservoir systems, the drug is released through micropores, which are generally filled with water or oil.
Diffusion-controlled
monolithic
systems
can
further
be
classified
according
to
the
concentration
of
the
incorporated drug. In these systems, the drug is loaded into a polymer matrix by soaking the polymer in a
drug solution. The drug concentration within the matrix cannot exceed its solubility in the polymer. When the
drug loading exceeds its solubility, the system is referred to as a monolithic dispersion.[12-15]
Fick's Law of Diffusion:
Fick's law describes the flux of a drug, expressed as the amount passing through a
unit area per unit time, across a membrane in the direction of decreasing concentration.
The release rate of a
drug
from
a
diffusion-controlled
system
depends
on
its
diffusion
through
the
inner
and
outer
insoluble
membrane barriers.[15]
Reservoir
Type:
In
a
reservoir
system,
a
drug-containing
core
is
enclosed
within
a
water-insoluble
polymeric
material
that
controls
the
release
rate.
When
the
dosage
form
comes
into
contact
with
the
surrounding
fluid,
the
fluid
enters
the
polymer
membrane,
exchanges
with
the
surrounding
medium,
and
allows the drug to diffuse through the polymer toward the exterior. Ethyl cellulose and polyvinyl acetate are
commonly used polymers in these systems.
Advantages
Disadvantages
-
•
The system must be physically removed from the implantation site.
-
•
Delivery of high-molecular-weight compounds is difficult.
-
•
The cost per dosage unit is generally increased.
-
•
Toxicity may occur if the system fails.[16-17]
Matrix Type;
In a matrix system, a solid drug powder is uniformly distributed throughout an insoluble, rate-
controlling
matrix.
Materials
such
as
beeswax,
carnauba
wax,
hydrogenated
castor
oil,
and
other
suitable
waxes are used to prepare these matrices.
These waxes regulate drug dissolution by controlling the rate at which the drug dissolves in the surrounding
fluid
and
subsequently
penetrates
the
matrix.
The
medium
affects
matrix
porosity,
while
the
tablet's
wettability or dissolution characteristics also influence the release rate.
Drug
release
from
such
matrices
generally
follows
first-order
kinetics.
The
matrix
may
be
prepared
by
dispersing the drug in molten wax, followed by solidification and granulation. The release rate is influenced
by drug diffusion rather than solely by the rate of dissolution.[17]
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 53
Advantages
Disadvantages
Osmosis-Based
Formulations:
Osmosis
is
the
movement
of
a
solvent,
such
as
water,
from
a
region
of
higher solvent concentration to a region of lower solvent concentration through a semipermeable membrane.
In
drug
delivery,
this
principle
is
used
to
develop
systems
capable
of
providing
zero-order
drug
release.
Osmotic formulations are prepared by enclosing an osmotic drug core, containing an osmotically active drug
or a mixture of an osmotically inactive drug with an osmotically active salt such as sodium chloride (NaCl),
within
a
semipermeable
membrane
made
of
biocompatible
polymers,
such
as
cellulose
acetate.
When
an
osmotic
pressure
gradient
develops,
water
continuously
enters
the
tablet
through
the
membrane.
The
dissolved drug is
then pumped out
through a delivery orifice. This
process
can
continue for an
extended
period, approximately 24 hours.
The drug-release rate is independent of the gastrointestinal environment but
depends on the osmotic pressure of the release medium.
The manufacturing process for osmotic systems is
complex.
Basic Osmotic Systems
Basic osmotic systems can deliver only water-soluble drugs. Water-insoluble drugs may be delivered using
push-pull osmotic systems.
In push-pull systems, a non-swelling solubilizing agent enhances the solubility of the insoluble drug, while a
non-swelling
agent
increases
the
contact
surface
area
between
the
drug
and
the
incoming
aqueous
liquid
distributed throughout the formulation.
Different
polymer
membranes
have
different
water-vapour
transmission
values.
The
selection
of
a
semipermeable membrane therefore depends on the intended application.[18-22]
Types of Osmotic Systems
Type A: Drug present in the osmotic core
: The drug is incorporated directly into the osmotic core, which is
surrounded by a semipermeable rigid membrane.
Type B: Osmotic core without drug
: The osmotic core does not directly contain the drug; instead, the drug
is present in a separate solution within a flexible membrane.
Types of Osmotic Pumps
-
•
Basic
osmotic
pump:
Water
enters
the
osmotic
drug
core
through
the
membrane,
and
the
drug
solution exits through the delivery orifice.
-
•
Push-pull osmotic pump:
Water enters the system, while the push layer helps expel the drug through
the delivery orifice.[22]
Ion-Exchange-Controlled
Drug
Release:
Ion-exchange
resins
are
used
to
regulate
the
release
of
drugs.
These
resins
are
water-insoluble
polymeric
materials
containing
ionic
groups.
Through
electrostatic
interactions, drug molecules bind to oppositely charged ionic groups present on the resin. Drug molecules
can
exchange
with
other
ions
carrying
the
same
charge.
As
a
result,
the
drug
is
released
from
the
ion-
exchange resin. This principle is used to prepare controlled-release dosage forms containing either anionic or
cationic drugs.
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 54
Method of Preparation
The preparation of ion-exchange-controlled drug formulations involves the following steps:
-
1.
Drug
absorption:
The
ionized
drug
is
absorbed
onto
ion-exchange
resin
granules.
For
example,
codeine base (drug) is absorbed onto Amberlite (resin).
-
2.
Filtration: The drug-loaded resin is separated from the alcoholic medium by filtration.
-
3.
Polymer
coating:
The
filtered
drug–resin
complex
granules
are
coated
with
a
water-permeable
polymer, such as a modified copolymer of polyacrylic and methacrylic ester, using the spray-drying
method.[23]
Mechanism of Drug Release:
In the gastrointestinal tract, the drug is released when appropriately charged
ions replace the drug bound to the resin. The released drug then diffuses out of the resin.
Drug release depends on:
Factors Controlling the Rate of Diffusion
The rate of drug diffusion from the resin is controlled by three factors:
-
1.
Area of diffusion.
-
2.
Length of the diffusion path.
-
3.
Rigidity of the resin.
Advantages
Limitations
-
•
The drug-release rate is proportional to the concentration of ions present near the resin granules at the
site of administration.
-
•
The release rate varies depending on diet, water intake, and intestinal contents.[23-24]
Processes Used to Prepare Controlled-Release Formulations:
Oral controlled-release (CR) formulations
are developed using drug-release mechanisms such as dissolution, diffusion, and osmosis.
The approaches or technologies used to prepare these formulations can be broadly classified into three types:
-
1.
Matrix tablets
-
2.
Multiparticulate formulations
-
3.
Osmotic tablets
Drug
Selection
for
Controlled
Drug
Delivery
Systems
(CDDS):
The selection of a suitable drug for a
controlled
drug
delivery
system
depends
on
its physicochemical,
pharmacokinetic,
and
pharmacodynamic
properties.[25-27]
Physicochemical
Properties:
These
properties
determine
the
drug's
solubility,
diffusion,
membrane
permeability, and suitability for controlled release.
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 55
-
1.
Molecular weight: Drugs with a molecular weight below 1000 Da are generally considered suitable
because molecular size influences their ability to diffuse through membranes.
-
2.
Aqueous solubility: The drug should have adequate water solubility to dissolve in body fluids and
become available for absorption. Drugs with extremely low solubility can be difficult to formulate
into controlled-release dosage forms.
-
3.
Apparent partition coefficient: This describes the distribution of a drug between oil and water. An
appropriate
partition
coefficient
is
important
for
drug
movement
through
lipid
membranes.
Both
excessively high and low values may affect absorption and drug release.
-
4.
pKa and ionization: The pKa of a drug and the pH of its surrounding medium determine its degree of
ionization. The unionized form generally crosses lipid membranes more readily than the ionized form.
-
5.
Drug stability: The drug should remain sufficiently stable in the gastrointestinal environment. Drugs
that
degrade
in
gastrointestinal
fluids
may
be
unsuitable
for
conventional
oral
controlled-release
formulations.
-
6.
Mechanism
and
site
of
absorption:
The
drug's
absorption
mechanism
and
the
region
of
the
gastrointestinal tract where absorption occurs influence its suitability. Drugs absorbed throughout the
gastrointestinal tract are generally more suitable than those absorbed only at a specific site.
-
7.
Route
of
administration:
The
route
must
be
appropriate
for
the
drug's
properties
and
the
intended
release pattern. The chapter discusses oral, parenteral, and transdermal routes in relation to controlled
drug delivery.[28-32]
Biological
Properties:
Biological
properties
are
divided
into
pharmacokinetic
and
pharmacodynamic
properties.
A. Pharmacokinetic Properties
Pharmacokinetics describes what the body does to a drug, including its absorption, distribution, metabolism,
and elimination.
-
1.
Absorption rate: The drug should be absorbed at an appropriate rate after its release from the dosage
form.
Its
absorption
characteristics
influence
the
duration
and
effectiveness
of
controlled
drug
delivery.
-
2.
Biological half-life: This is the time required for the drug concentration in the body to decrease by
half. According to the chapter, drugs with a half-life of approximately 2–4 hours are ideal candidates
for controlled-release formulations. Drugs with very long half-lives are generally less suitable.
-
3.
Rate of metabolism: The rate at which the body metabolizes a drug influences its concentration and
duration of action. Drugs that undergo excessively rapid metabolism or alter their own metabolism
may be unsuitable for controlled release.
-
4.
Drug distribution: The distribution of a drug throughout the body affects its concentration at the site
of action and its elimination. Therefore, distribution characteristics must be considered when selecting
a drug for controlled release.
-
5.
Drug–protein binding: Drugs bind to proteins in plasma to varying degrees. Extensive protein binding
may
prolong
the
drug's
half-life
and
make
it
less
suitable
for
sustained-
or
controlled-release
formulations.
-
6.
Dosage
form
index:
This
is
the
ratio
of
the
maximum
steady-state
concentration
to
the
minimum
steady-state
concentration.
A
value
close
to
1
indicates
less
fluctuation
between
maximum
and
minimum steady-state drug concentrations.[33]
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 56
B. Pharmacodynamic Properties
Pharmacodynamics describes the relationship between drug concentration and its effects on the body.
-
1.
Therapeutic
range:
This
is
the
range
of
drug
concentrations
between
the
minimum
effective
concentration
and
the
concentration
at
which
toxicity
may
occur.
A
sufficiently
wide
therapeutic
range is desirable because variations in drug release are less likely to produce toxic concentrations.
-
2.
Therapeutic index:
The therapeutic index indicates the safety margin of a drug. A higher therapeutic
index
indicates
a
wider
safety
margin,
whereas
drugs
with
a
very
low
therapeutic
index
are
less
suitable for controlled-release formulations.
-
3.
Plasma
concentration–response
relationship:
This
describes
how
changes
in
plasma
drug
concentration
influence
its
pharmacological
effect.
Drugs
whose
effects
are
independent
of
their
concentration,
such
as
reserpine
according
to
the
chapter,
are
considered
poor
candidates
for
controlled-release systems.[34]
CONCLUSION
Controlled
Drug
Delivery
Systems
(CDDS)
represent
an
important
advancement
in
pharmaceutical
formulation, designed to regulate the rate, duration, and, where appropriate, site of drug release to achieve the
desired therapeutic effect. Unlike conventional dosage forms, which generally release the drug more rapidly,
controlled-release
formulations
aim
to
maintain
drug
concentrations
within
the
therapeutic
range
for
a
prolonged period and reduce fluctuations in plasma drug levels. The successful design of CDDS depends on
the
careful
selection
of
a
suitable
drug
based
on
its
physicochemical,
pharmacokinetic,
and
pharmacodynamic
properties.
Factors
such
as
molecular
weight,
aqueous
solubility,
partition
coefficient,
drug stability, absorption characteristics, biological half-life, metabolism, therapeutic range, and therapeutic
index
play
important
roles
in
determining
the
suitability
of
a
drug
for
controlled
release.
A
thorough
understanding
of
these
characteristics
helps
in
selecting
an
appropriate
formulation
strategy
and
release
mechanism.
Overall,
CDDS
can
help
reduce
the
frequency
of
drug
administration,
improve
patient
compliance,
minimize
fluctuations
in
drug
concentrations,
and
maintain
therapeutic
effectiveness
over
an
extended
period.
However,
their
successful
application
depends
on
appropriate
drug
selection,
rational
formulation
design,
and
consideration
of
the
limitations
associated
with
individual
drugs
and
delivery
systems. Therefore, the integration of drug properties with suitable formulation technologies is fundamental
to the development of safe, effective, and reliable controlled drug delivery systems.
REFERENCES
-
1.
Allen, LV; Popovich, GN and Ansel, HC (2004),
Ansel's Pharmaceutical Dosage Forms and Drug
Delivery System
, Lippincott Williams & Wilkins.
-
2.
Banker, SG and Rhodes, TC (2002),
Modern Pharmaceutics
, Marcel Dekker Inc., New York, 575.
-
3.
Bhargava, A; Rathore, RPS; Tanwar, YS; Gupta, S and Bhaduka, G (2013), "Oral sustained release
dosage form: an opportunity to prolong the release of drug",
Int J Adv Res Pharm Bio Sci
, Vol. 3 (1),
7–14.
-
4.
Chauhan,
MJ
and
Patel,
SA
(2012),
"A
concise
review
on
sustained
drug
delivery
system
and
its
opportunities",
Am J Pharm Tech Res
, Vol. 2 (2), 227–238.
-
5.
Chugh, I; Seth, N; Rana, AC and Gupta, S (2012), "Oral sustained release drug delivery system: an
overview",
Int Res J Pharm
, Vol. 3 (5), 57–62.
-
6.
Cristina, M; Aranzazu, Z and Jose, ML (2011), "Critical factors in the release of drugs from sustained
release hydrophilic matrices",
J Control Rel
, Vol. 154, 2–19.
-
7.
Dusane,
AR;
Gaikwad,
PD;
Bankar,
VH
and
Pawar,
SP
(2011),
"A
review
on
sustained
released
technology",
Int J Res Ayu Pharm
, Vol. 2 (6), 1701–1708.
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 57
-
8.
John,
C
and
Morten,
C
(2002),
The
Science
of
Dosage
Form
Design:
Modified
Release
Peroral
Dosage Forms
, Churchill Livingstone.
-
9.
Kamboj,
S
and
Gupta,
GD
(2009),
"Matrix
tablets:
an
important
tool
for
oral
controlled
release
dosage forms",
Pharmainfonet
, Vol. 7, 1–9.
-
10.
Kar,
RK;
Mohapatra,
S
and
Barik,
BB
(2009),
"Design
and
characterization
of
controlled
release
matrix tablets of zidovudine",
Asian J Pharm Clin Res
, Vol. 2, 54.
-
11.
Kube, RS;
Kadam,
VS; Shendarkar, GR; Jadhav, SB and Bharkad, VB (2015), "Sustained release
drug delivery system: review",
Int J Res Pharm Biotech
, Vol. 3 (3), 246–251.
-
12.
Kumar, S; Shashikant and Bharat, P (2012), "Sustained release drug delivery system: a review",
Int J
Pharm Life Sci
, Vol. 3 (12), 356–376.
-
13.
Lapidus, H and Lordi, NG (1968), "Studies on controlled release formulations",
J Pharm Sci
, Vol. 57,
1292.
-
14.
Lachman, L; Lieberman, HA and Kanig, JL (1982),
The Theory and Practice of Industrial Pharmacy
,
3rd ed., Varghese Publishing House, Bombay, 419–428.
-
15.
Mali, AD and Bathe, AS (2015), "A review on sustained release drug delivery system",
GCC J Sci
Tech
, Vol. 1 (4), 107–123.
-
16.
Mamidala,
R;
Ramana,
V;
Lingam,
M;
Gannu,
R
and
Rao,
MY
(2009),
"Review
article:
factors
influencing
the
design
and
performance
of
oral
sustained/controlled
release
dosage
form",
Int
J
Pharm Sci Nanotechnology
, Vol. 2, 583.
-
17.
Mohd,
Abdul
Hadi;
Raghavendra
Rao,
NG
and
Sandeep,
T
(2012),
"Novel
technologies
in
formulations: an overview",
World J Pharm Res
, Vol. 1 (3), 452.
-
18.
Nalla, C; Gopinath, H; Debjit, B; Williambkeri, I and Reddy, TA (2013), "Modified release dosage
forms",
J Chem Pharm Sci
, Vol. 6 (1), 13–21.
-
19.
Patel,
K;
Patel,
U;
Bhimani,
B
and
Patel,
G
(2012),
"Extended
oral
drug
delivery
system",
Int
J
Pharm Res Biosci
, Vol. 1 (3), 2.
-
20.
Patel, PN; Patel, MM; Rathod, DM; Patel, JN and Modasiya, MMK (2012), "Sustain release drug
delivery: a theoretical prospective",
J Pharm Res
, Vol. 8 (8), 4165–4168.
-
21.
Patnaik, AN; Nagarjuna, T and Thulasiramiraju, TV (2013), "Sustained release drug delivery system:
a modern formulation approach",
Int J Res Pharm Nano Sci
, Vol. 2 (5), 586–601.
-
22.
Almoshari,
Y
(2022),
"Osmotic
pump
drug
delivery
systems—a
comprehensive
review",
Pharmaceuticals
, Vol. 15 (11), Article 1430.
https://doi.org/10.3390/ph15111430
-
23.
Guo,
X;
Chang,
RK
and
Hussain,
MA
(2009),
"Ion-exchange
resins
as
drug
delivery
carriers",
J
Pharm Sci
, Vol. 98 (11), 3886–3902.
https://doi.org/10.1002/jps.21706
-
24.
Chaudhary, NC and Saunders, L (1956), "Sustained release of drugs from ion exchange resins",
J
Pharm Pharmacol
, Vol. 8 (1), 975–986.
-
25.
Ratilal, D; Abhijit, G; Priti, D and Bankar, V (2011), "A review on sustained release technology",
Int
J Res Ayurveda Pharm
, Vol. 2 (6), 1.
-
26.
Robinson, JR and Lee, VH (1987),
Controlled Drug Delivery
, Marcel Dekker.
-
27.
Salsa, T and Veiga, F (1997), "Oral controlled release dosage form. II. Cellulose ether polymers in
hydrophilic matrices",
Drug Dev Ind Pharm
, Vol. 23 (9), 929–938.
-
28.
Shamma, SP; Haranath, C; Reddy, CPS and Sowmya, C (2013), "An overview on sustained-release
tablet and its technology",
Int J Pharm Drug Anal
, Vol. 2 (9), 740–747.
-
29.
Shargel, L and Yu, ABC (1999), "Modified release drug products", in
Applied Biopharmaceutics and
Pharmacokinetics
, McGraw-Hill.
-
30.
Swarbrick, J and Boylan, JC (1996),
Encyclopedia of Pharmaceutical Technology
, Marcel Dekker,
New York.
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 58
-
31.
Thombre, NA; Aher, AS; Wadkar, AV and Kshirsagar, SJ (2015), "A review on sustained release oral
drug delivery system",
Int J Pharm Res Sci
, Vol. 4 (2), 361–371.
-
32.
Ummadi, S; Shravani, B; Rao, NGR; Reddy, MS and Nayak, BS (2013), "Overview on controlled
release dosage form",
Int J Pharm Sci
, Vol. 3 (4), 258–269.
-
33.
Alagga,
AA;
Pellegrini,
MV
and
Gupta,
V
(2024),
"Drug
absorption",
in
StatPearls
[Internet],
StatPearls
Publishing,
Treasure
Island,
FL,
USA.
Available
at:
https://www.ncbi.nlm.nih.gov/books/NBK557405/
(Accessed: [insert access date]).
-
34.
Marino, M; Jamal, Z and Zito, PM (2023), "Pharmacodynamics", in
StatPearls
[Internet], StatPearls
Publishing,
Treasure
Island,
FL,
USA.
Available
at:
https://www.ncbi.nlm.nih.gov/books/NBK507791/
(Accessed: [insert access date]).
How to cite this article:
Vivek Dinanath Parab, Kashish Irfan Kazi. Controlled Drug Delivery Systems: Mechanisms, Drug Selection,
and
Formulation
Approaches.
(2026).
International
Journal
of
Pharmaceutical
Research
and
Medicinal
Plants
,
2
(5),44-
59.
https://doi.org/10.61280/6jj8a660
Published by:
Informative Journals
Jadoun Science Publishing Group India
Vivek Dinanath Parab
/
International Journal of Pharmaceutical Research and Medicinal Plants
2026, Vol. 2 (5), 45-59
https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants
Page | 59